| 11/16/2026 7:15 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2026 7:45 AM | CG Oncology (1991792) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2026 7:30 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/19/2026 3:30 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/19/2026 3:30 PM | CG Oncology (1991792) Issuer Kalofonos Isabel (1975163) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/19/2026 3:15 PM | CG Oncology (1991792) Issuer Kalofonos Isabel (1975163) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/15/2026 3:41 PM | CG Oncology (1991792) Subject POST LEONARD E (1235862) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/21/2026 3:04 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/17/2026 3:30 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 3:33 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/11/2026 4:10 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CGON and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/02/2026 4:02 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/31/2026 3:50 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/27/2026 4:07 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/24/2026 4:12 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/19/2026 3:05 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 3:30 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/17/2026 3:09 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2026 6:00 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2026 6:58 AM | CG Oncology (1991792) Subject RTW INVESTMENTS, LP (1493215) Filed by | Form SCHEDULE 13G/A | |
| 08/13/2026 4:07 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 3:05 PM | CG Oncology (1991792) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 4:43 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2026 5:05 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:03 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/07/2026 3:39 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 3:16 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 7:45 AM | CG Oncology (1991792) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/06/2026 7:30 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 7:00 AM | CG Oncology (1991792) Filer | Form 424B5 | |
| 08/05/2026 3:32 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/17/2026 3:15 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 3:24 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/14/2026 3:15 PM | CG Oncology (1991792) Issuer Mulay James (1684531) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2026 3:41 PM | CG Oncology (1991792) Subject Mulay James (1684531) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2026 4:06 PM | CG Oncology (1991792) Subject Mulay James (1684531) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 4:26 PM | CG Oncology (1991792) Issuer Liu Brian Guan-Chyun (2007835) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 3:30 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2026 3:37 PM | CG Oncology (1991792) Subject POST LEONARD E (1235862) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/23/2026 3:30 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:49 PM | CG Oncology (1991792) Subject POST LEONARD E (1235862) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Every Starlink dish pays this stock (Ad) There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it.
Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th.
This free pick names the public company collecting on every unit. Claim your free stock pick before December 8th |
| 06/16/2026 4:07 PM | CG Oncology (1991792) Issuer Mulay James (1684531) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:02 PM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/04/2026 3:29 PM | CG Oncology (1991792) Subject POST LEONARD E (1235862) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/26/2026 7:00 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 9:06 AM | CG Oncology (1991792) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 7:16 AM | CG Oncology (1991792) Subject RTW INVESTMENTS, LP (1493215) Filed by | Form SCHEDULE 13G | |
| 05/08/2026 3:15 PM | CG Oncology (1991792) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/08/2026 7:45 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 3:30 PM | CG Oncology (1991792) Filer | Form DEF 14A | |
| 04/24/2026 3:31 PM | CG Oncology (1991792) Filer | Form DEFA14A | |
| 04/24/2026 3:32 PM | CG Oncology (1991792) Filer | Form ARS | |
| 04/20/2026 3:15 PM | CG Oncology (1991792) Issuer Mulay James (1684531) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:34 PM | CG Oncology (1991792) Subject Mulay James (1684531) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/16/2026 3:15 PM | CG Oncology (1991792) Issuer Kuan Arthur (2007101) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 3:15 PM | CG Oncology (1991792) Issuer DETORE JAMES M. (1623981) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 3:15 PM | CG Oncology (1991792) Issuer Patterson Joshua F. (1805702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 3:15 PM | CG Oncology (1991792) Issuer Kasturi Vijay (2007109) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 3:15 PM | Bellete Ambaw (2007090) Reporting CG Oncology (1991792) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/13/2026 7:30 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/26/2026 4:13 PM | CG Oncology (1991792) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/13/2026 3:09 PM | CG Oncology (1991792) Issuer Kuan Arthur (2007101) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 4:52 PM | CG Oncology (1991792) Issuer Kuan Arthur (2007101) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/27/2026 8:08 AM | CG Oncology (1991792) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/27/2026 8:00 AM | CG Oncology (1991792) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/27/2026 7:45 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 3:51 PM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 3:47 PM | CG Oncology (1991792) Filer | Form 424B5 | |
| 01/13/2026 3:15 PM | CG Oncology (1991792) Issuer Mulay James (1684531) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:32 PM | CG Oncology (1991792) Subject Mulay James (1684531) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/09/2026 7:45 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/26/2025 3:30 PM | CG Oncology (1991792) Issuer Rossi Christina (1756941) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:15 PM | CG Oncology (1991792) Issuer Rossi Christina (1756941) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 11/26/2025 6:30 AM | CG Oncology (1991792) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/24/2025 3:30 PM | CG Oncology (1991792) Issuer DETORE JAMES M. (1623981) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 11/18/2025 3:30 PM | CG Oncology (1991792) Issuer POST LEONARD E (1235862) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |